Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 233Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Faran Shimi Pharmaceutical

02 4Alfred E Tiefenbacher GmbH

03 2Pharmathen SA

04 4Alfasigma

05 1Alvogen

06 1Clinigen Group

07 1Cooper Pharma Limited

08 2Grunenthal

09 2Intas Pharmaceuticals

10 2Norgine

11 1Norgine Pty. Ltd.

12 1Norwich Pharmaceuticals

13 2Pluviaendo

14 1Qilu Animal Health Products

15 4Salix Pharmaceuticals

16 1Sandoz B2B

17 3Titan Laboratories

18 2ZRS LABS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFaran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

Regulatory Info :

Registration Country : Iran

Rifaximin

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

Faran Shimi Pharmaceutical

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Regulatory Info : EU Dossier Readiness-Q1 2020

Registration Country : Germany

Rifaximin

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Dossier Readiness-Q1 2020

Registration Country : Germany

Tiefenbacher Compnay Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info :

Registration Country : Greece

Rifaximin

Brand Name :

Dosage Form : Tablet

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Greece

Pharmathen

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFaran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

Regulatory Info :

Registration Country : Iran

Rifaximin

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 550MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

Faran Shimi Pharmaceutical

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Regulatory Info : EU Dossier Readiness-Q1 2020

Registration Country : Germany

Rifaximin

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 550MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Dossier Readiness-Q1 2020

Registration Country : Germany

Tiefenbacher Compnay Banner

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Regulatory Info : EU Dossier Readiness-Q1 2020

Registration Country : Germany

Rifaximin

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Dossier Readiness-Q1 2020

Registration Country : Germany

Tiefenbacher Compnay Banner

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Regulatory Info : EU Dossier Readiness-Q1 2020

Registration Country : Germany

Rifaximin

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 550MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Dossier Readiness-Q1 2020

Registration Country : Germany

Tiefenbacher Compnay Banner

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info :

Registration Country : Greece

Rifaximin

Brand Name :

Dosage Form : Tablet

Dosage Strength : 550MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Greece

Pharmathen

09

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

rifaximin

Brand Name : Tixteller

Dosage Form : FILM COATED PILL

Dosage Strength : 550 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

10

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

Rifaximin

Brand Name : Normix

Dosage Form : Rifaximin 200Mg 12 Combined Oral Use

Dosage Strength : 12 cpr riv 200 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

11

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

Rifaximin

Brand Name : Normix

Dosage Form : Rifaximin 60Ml 100Mg/Ml Oral Use

Dosage Strength : os grat suspe 60 ml 2 g/100 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

12

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

RIFAXIMIN

Brand Name : RIFAXIMIN

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number : 214370

Regulatory Info :

Registration Country : USA

blank

13

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

Rifaximin

Brand Name : Rifacol

Dosage Form : Rifaximin 200Mg 12 Combined Oral Use

Dosage Strength : AD 12 cpr riv 200 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

14

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

Rifaximin

Brand Name : Rifacol

Dosage Form : Rifaximin 60Ml 100Mg/Ml Oral Use

Dosage Strength : os grat suspe 60 ml 2 g/100 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

15

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

Rifaximin

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

16

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

Rifaximin

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 550MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

17

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

rifaximin

Brand Name : Xifaxan

Dosage Form : FILM COATED PILL

Dosage Strength : 550 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

18

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

Rifaximin

Brand Name : Xifaxan

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 550 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

19

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

RIFAXIMIN

Brand Name : RIFAXIMIN

Dosage Form : TABLET;ORAL

Dosage Strength : 550MG

Packaging :

Approval Date :

Application Number : 214369

Regulatory Info :

Registration Country : USA

blank

20

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

Rifaximin

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

21

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

Rifaximin

Brand Name :

Dosage Form : Intramammary Infusion

Dosage Strength : 100MG

Packaging : 5 g

Approval Date :

Application Number :

Regulatory Info :

Registration Country : China

blank

22

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

RIFAXIMIN

Brand Name : XIFAXAN

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG

Packaging :

Approval Date : 2004-05-25

Application Number : 21361

Regulatory Info : RX

Registration Country : USA

blank

23

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

RIFAXIMIN

Brand Name : XIFAXAN

Dosage Form : TABLET;ORAL

Dosage Strength : 550MG

Packaging :

Approval Date : 2010-03-24

Application Number : 21361

Regulatory Info : RX

Registration Country : USA

blank

24

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

RIFAXIMIN

Brand Name : XIFAXAN

Dosage Form : TABLET;ORAL

Dosage Strength : 550MG

Packaging :

Approval Date :

Application Number : 22554

Regulatory Info :

Registration Country : USA

blank

25

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

RIFAXIMIN

Brand Name : RIFAXIMIN

Dosage Form : TABLET;ORAL

Dosage Strength : 550MG

Packaging :

Approval Date :

Application Number : 213713

Regulatory Info :

Registration Country : USA

blank

26

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

Rifaximin

Brand Name :

Dosage Form : Tablet

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

27

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

Rifaximin

Brand Name :

Dosage Form : Tablet

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

28

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

Rifaximin

Brand Name :

Dosage Form : Tablet

Dosage Strength : 550MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

29

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

Rifaximin

Brand Name :

Dosage Form : Tablet

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

30

MAGHREB PHARMA
Not Confirmed
arrow
arrow
MAGHREB PHARMA
Not Confirmed

Rifaximin

Brand Name :

Dosage Form : Tablet

Dosage Strength : 400MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank